CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Conjunctival swab and nasopharyngeal swabWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug951 Flexitouch Plus with Cellular Connectivity (FT-CC) Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D000072656 Breast Cancer Lymphedema NIH 1.00
D008209 Lymphedema NIH 1.00
D001943 Breast Neoplasms NIH 0.50

Correlated HPO Terms (2)


Name (Synonyms) Correlation
HP:0001004 Lymphedema HPO 1.00
HP:0003002 Breast carcinoma HPO 0.50

There is one clinical trial.

Clinical Trials


1 Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19

The aim of this possible study is to identify if SARS-CoV-2 can be found in the tear film and conjunctiva of a patient with COVID-19.

NCT04444596 COVID-19 SARS-CoV 2 Diagnostic Test: Conjunctival swab and nasopharyngeal swab

Primary Outcomes

Description: The primary endpoint is the number of conjunctival swabs tested positive for SARS-CoV2.

Measure: SARS-CoV2 positive conjunctival swabs

Time: 1 year

Secondary Outcomes

Description: The secondary target is the difference between the conjunctival swab tested positive for SARS-CoV2 and the nasopharyngeal swab.

Measure: Conjunctival swab vs nasopharyngeal swab

Time: 1 year

Other Outcomes

Description: In the case of a SARS-COV 2 positive conjunctival swab a virus culture will be conducted to clarify, whether it is a viable virus or virus RNA fragments.

Measure: Viability of SARS-COV 2

Time: 1 year


No related HPO nodes (Using clinical trials)